ECO Animal Health Group (EAH) Competitors

GBX 116
-2.00 (-1.69%)
(As of 06:27 AM ET)

EAH vs. CEL, VLG, ANCR, AGY, BXP, APH, POLB, SPEC, DXRX, and BVC

Should you be buying ECO Animal Health Group stock or one of its competitors? The main competitors of ECO Animal Health Group include Celadon Pharmaceuticals (CEL), Venture Life Group (VLG), Animalcare Group (ANCR), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Alliance Pharma (APH), Poolbeg Pharma (POLB), INSPECS Group (SPEC), Diaceutics (DXRX), and BATM Advanced Communications (BVC). These companies are all part of the "medical" sector.

ECO Animal Health Group vs.

Celadon Pharmaceuticals (LON:CEL) and ECO Animal Health Group (LON:EAH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Celadon Pharmaceuticals currently has a consensus target price of GBX 222.50, indicating a potential upside of 102.27%. Given ECO Animal Health Group's higher probable upside, research analysts clearly believe Celadon Pharmaceuticals is more favorable than ECO Animal Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celadon Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

5.5% of Celadon Pharmaceuticals shares are owned by institutional investors. Comparatively, 88.2% of ECO Animal Health Group shares are owned by institutional investors. 66.1% of Celadon Pharmaceuticals shares are owned by company insiders. Comparatively, 16.6% of ECO Animal Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Celadon Pharmaceuticals has a beta of -0.02, meaning that its stock price is 102% less volatile than the S&P 500. Comparatively, ECO Animal Health Group has a beta of 0.07, meaning that its stock price is 93% less volatile than the S&P 500.

In the previous week, ECO Animal Health Group had 3 more articles in the media than Celadon Pharmaceuticals. MarketBeat recorded 3 mentions for ECO Animal Health Group and 0 mentions for Celadon Pharmaceuticals. Celadon Pharmaceuticals' average media sentiment score of 0.20 beat ECO Animal Health Group's score of 0.00 indicating that ECO Animal Health Group is being referred to more favorably in the news media.

Company Overall Sentiment
Celadon Pharmaceuticals Neutral
ECO Animal Health Group Neutral

Celadon Pharmaceuticals has a net margin of 0.00% compared to Celadon Pharmaceuticals' net margin of -1.83%. Celadon Pharmaceuticals' return on equity of -0.24% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Celadon PharmaceuticalsN/A -122.33% -35.60%
ECO Animal Health Group -1.83%-0.24%0.69%

ECO Animal Health Group has higher revenue and earnings than Celadon Pharmaceuticals. ECO Animal Health Group is trading at a lower price-to-earnings ratio than Celadon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celadon Pharmaceuticals£11.26K6,273.85-£7.96M-£0.13-846.15
ECO Animal Health Group£88.46M0.89-£1.62M-£0.02-5,800.00

ECO Animal Health Group received 289 more outperform votes than Celadon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Celadon Pharmaceuticals an outperform vote while only 75.71% of users gave ECO Animal Health Group an outperform vote.

CompanyUnderperformOutperform
Celadon PharmaceuticalsOutperform Votes
4
100.00%
Underperform Votes
No Votes
ECO Animal Health GroupOutperform Votes
293
75.71%
Underperform Votes
94
24.29%

Summary

ECO Animal Health Group beats Celadon Pharmaceuticals on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EAH vs. The Competition

MetricECO Animal Health GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£78.58M£1.16B£4.99B£1.43B
Dividend Yield0.94%2.98%39.36%11.86%
P/E Ratio-5,800.00525.69141.801,667.28
Price / Sales0.8910,587.512,302.23343,600.48
Price / Cash6.0510.5632.6732.85
Price / Book0.977.734.962.71
Net Income-£1.62M£167.88M£103.89M£174.97M
7 Day Performance3.11%0.71%-0.56%0.94%
1 Month Performance22.11%0.02%-0.91%3.04%
1 Year Performance-4.13%33.37%5.18%10.42%

ECO Animal Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 101.50
flat
GBX 222.50
+119.2%
-25.0%£65.17M£11,258.00-780.7724News Coverage
Gap Up
VLG
Venture Life Group
0 of 5 stars
GBX 40.50
+1.3%
N/A-2.9%£51.23M£48.57M-4,050.00153
ANCR
Animalcare Group
0 of 5 stars
GBX 227
-3.8%
N/A+19.1%£136.45M£74.35M11,350.00220High Trading Volume
AGY
Allergy Therapeutics
0 of 5 stars
GBX 3.12
+8.7%
N/AN/A£148.82M£53.26M-52.00612High Trading Volume
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 37.50
flat
N/A+9.3%£167.29M£41.65B468.755,700News Coverage
APH
Alliance Pharma
2.9678 of 5 stars
GBX 32
-3.3%
GBX 80.75
+152.3%
-52.6%£172.93M£170.05M-3,200.00285Gap Up
High Trading Volume
POLB
Poolbeg Pharma
0 of 5 stars
GBX 14.90
+11.6%
N/A+78.8%£74.50MN/A-1,490.0012Positive News
High Trading Volume
SPEC
INSPECS Group
0 of 5 stars
GBX 70
+12.9%
N/A-45.2%£71.17M£202M-3,500.001,673High Trading Volume
DXRX
Diaceutics
0 of 5 stars
GBX 97.50
-0.5%
GBX 150
+53.8%
+1.0%£82.56M£21.90M10,500.00151
BVC
BATM Advanced Communications
0 of 5 stars
GBX 19.75
+0.5%
N/A-26.2%£86.15M£122.83M2,800.00980Positive News

Related Companies and Tools

This page (LON:EAH) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners